These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7509158)

  • 21. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T; Dong B; Ishii K; Kinemuchi H
    J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
    Brannan T; Prikhojan A; Yahr MD
    J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties.
    Antkiewicz-Michaluk L; Michaluk J; Mokrosz M; Romanska I; Lorenc-Koci E; Ohta S; Vetulani J
    J Neurochem; 2001 Jul; 78(1):100-8. PubMed ID: 11432977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of zonisamide on dopaminergic system.
    Okada M; Kaneko S; Hirano T; Mizuno K; Kondo T; Otani K; Fukushima Y
    Epilepsy Res; 1995 Nov; 22(3):193-205. PubMed ID: 8991786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered monamine metabolism in caudate-putamen of iron-deficient rats.
    Beard JL; Chen Q; Connor J; Jones BC
    Pharmacol Biochem Behav; 1994 Jul; 48(3):621-4. PubMed ID: 7524105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of noise on monoamine levels in the rat brain using in vivo microdialysis.
    Tsai HY; Lu YH; Wu CR; Chen YF
    Pflugers Arch; 2005 May; 450(2):83-7. PubMed ID: 15614574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal effects of acute harmaline exposure on fetal brain biogenic amine metabolism.
    Okonmah AD; Brown JW; Blyden GT; Soliman KF
    Pharmacology; 1988; 37(3):203-8. PubMed ID: 2465555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine-derived tetrahydroisoquinoline alkaloids--inhibitors of neuroamine metabolism.
    Collins AC; Cashaw JL; Davis VE
    Biochem Pharmacol; 1973 Sep; 22(18):2337-48. PubMed ID: 4733684
    [No Abstract]   [Full Text] [Related]  

  • 29. Temporal profile of aminergic neurotransmitter release in striatal dialysates in rats with post-ischemic seizures.
    Bentué-Ferrer D; Bellissant E; Decombe R; Allain H
    Exp Brain Res; 1994; 97(3):437-43. PubMed ID: 7514544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does monoamine oxidase inhibition by pargyline increase extracellular dopamine concentrations in the striatum?
    Blaha CD; Coury A; Phillips AG
    Neuroscience; 1996 Nov; 75(2):543-50. PubMed ID: 8931017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
    Treseder SA; Rose S; Jenner P
    Eur J Neurosci; 2001 Jan; 13(1):162-70. PubMed ID: 11135014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat.
    Männistö PT; Tuomainen P; Tuominen RK
    Br J Pharmacol; 1992 Mar; 105(3):569-74. PubMed ID: 1628144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
    Colzi A; D'Agostini F; Cesura AM; Borroni E; Da Prada M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):103-11. PubMed ID: 8473998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of chronic inhibition of dopamine-metabolizing enzymes in the regulation of renal sodium and phosphate excretion in the rat remnant kidney.
    Sampaio-Maia B; Moreira-Rodrigues M; Pestana M
    Nephron Physiol; 2006; 103(1):p14-24. PubMed ID: 16352914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: a PET study with 6-[18F]L-DOPA.
    Doudet DJ; Chan GL; Holden JE; Pate BD; Morrison KS; Calne DB; Ruth TJ
    Eur J Pharmacol; 1997 Sep; 334(1):31-8. PubMed ID: 9346324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of N-methyl-D-aspartate and potassium on striatal monoamine metabolism in immature rat: an in vivo microdialysis study.
    Nakajima W; Ishida A; Ogasawara M; Takada G
    Neurochem Res; 1998 Sep; 23(9):1159-65. PubMed ID: 9712185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biochemistry of depression and antidepressants].
    Strolin Benedetti M
    Encephale; 1982; 8(5):545-85. PubMed ID: 6189704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopaminergic and serotonergic neurotransmitters in bone marrow transplant patients.
    Davis DG; Sparks DL
    J Neurol Sci; 1995 May; 130(1):95-103. PubMed ID: 7544403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.